Ozempic’s Promise, SC Primary, Black Swing Voters
Listen now
Description
First, Ravi talks to Dr. Dhruv Khullar about Ozempic’s breakthrough and the potential impact it could have on medicine. They dive into the stigma and cost associated with the drug, as well as the long-term effects and potential price reduction. They also explore the rise of private sector full-body MRI scans and the pros and cons of this trend. Finally, New York Times reporter Maya King joins the show to discuss how both party’s South Carolina primaries are shaping up. And, how black voters across the South are feeling about another Trump v. Biden general election. Leave us a voicemail with your thoughts on the show! 321-200-0570 Subscribe to our feed on Spotify: http://bitly.ws/zC9K Subscribe to our Substack: https://thelostdebate.substack.com/ Follow The Branch on Instagram: https://www.instagram.com/thebranchmedia/ Follow The Branch on TikTok: https://www.tiktok.com/@thebranchmedia Follow The Branch on Twitter: https://twitter.com/thebranchmedia The Branch website: http://thebranchmedia.org/ Lost Debate is also available on the following platforms:  Apple: https://podcasts.apple.com/us/podcast/the-lost-debate/id1591300785 Google: https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vTERJNTc1ODE3Mzk3Nw  iHeart: https://www.iheart.com/podcast/269-the-lost-debate-88330217/ Amazon Music: https://music.amazon.co.uk/podcasts/752ca262-2801-466d-9654-2024de72bd1f/the-lost-debate
More Episodes
Ravi reacts to President Biden’s performance during the presidential debate, makes the case for Biden to step aside ahead of the Democratic National Convention, and calls for more accountability and honesty from left-wing media and the leadership within the Democratic Party. Leave us a voicemail...
Published 06/28/24
Published 06/28/24
In this special episode, Ravi is joined by Michael D. Shear, White House correspondent at The New York Times, to discuss what to expect from the upcoming presidential debate. They then turn to President Joe Biden’s closest advisers; who they are, why they’re largely unknown, and how they wield...
Published 06/27/24